activity serum alphaamylases cystic fibrosis new method us differential inhibitor measure pancreatic salivary type alphaamylases ec 3211 applied serum sample 46 cystic fibrosis cf patient age range 4 14 year 50 control age group level pancreatic type amylase lower cf patient median 265 iu1 control median 815 p le 0001 result salivarytype enzyme however support previously reported finding higher usual level cf patient discrepancy probably due difference analytical method felt procedure value investigation patient cystic fibrosis pancreatic disorder